Managbanag, Roberto .
HRN: 29-06-26 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/24/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
05/24/2026
05/31/2026
IV
2.25G
Q8H
UROSEPSIS
Checking Initial Appropriateness
05/27/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
05/27/2026
06/03/2026
IV
4.5g
Q8
Urosepsis
Checking Initial Appropriateness
05/29/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
05/29/2026
05/30/2026
IV
4.5g
Q8
Urosepsis
Checking Initial Appropriateness
05/29/2026
CEFIXIME 200MG (CAP)
05/29/2026
06/03/2026
PO
200mg
Q12
Uti
Checking Initial Appropriateness